This is an aggregated industry headline. Read the full story at FierceBiotech →
Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
Christelle Huguet, Ph.D., Ipsen's executive vice president and head of R&D, sits down with Fierce Healthcare & Life Sciences Editor-in-Chief Ayla Ellison to discuss pipeline discipline, external partnerships and key 2026 milestones.
By FierceBiotech
· Jun 14, 2026
· via FierceBiotech
Image: FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
An independent research firm is reviewing data on Amgen's Tavneos as the company prepares for a hearing with t…
The WeekFierceBiotech ↗
Boehringer Ingelheim's Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared …
The WeekBriefing
The Trump administration proposed changes aimed at closing a loophole in Medicare’s drug price negotiation fra…